Showing results (281-290 of 1,142) with videos related to
Sort By:
Pageof 115
JHEP Reports : Innovation in Hepatology|November 26, 2021
Early transplantation maximizes survival in severe acute-on-chronic liver failure: Results of a Markov decision process modelSuyanpeng Zhang, Sze-Chuan Suen, Cynthia L Gong, et al.Plos One|October 15, 2015
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control StudyDaniel D Murray, Kazuo Suzuki, Matthew Law, et al.Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosisHenning W Zimmermann, Alexander Koch, Sebastian Seidler, et al.Clinical Biochemistry|June 10, 2008
High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulinOlav A Gressner, Alexander Koch, Edouard Sanson, et al.Cancers|September 3, 2020
Deciphering the Immune Microenvironment on A Single Archival Formalin-Fixed Paraffin-Embedded Tissue Section by An Immediately Implementable Multiplex Fluorescence Immunostaining ProtocolAdrien Guillot, Marlene S Kohlhepp, Alix Bruneau, et al.JHEP Reports : Innovation in Hepatology|July 18, 2022
Understanding the cellular interactome of non-alcoholic fatty liver diseaseSebastian J Wallace, Frank Tacke, Robert F Schwabe, et al.Cancers|June 3, 2020
Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic CancerJanina Henze, Frank Tacke, Olaf Hardt, et al.BMC Gastroenterology|April 26, 2012
Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytesSebastian Seidler, Henning W Zimmermann, Ralf Weiskirchen, et al.Hepatology (Baltimore, Md.)|May 30, 2025
Bariatric surgery for metabolic dysfunction-associated steatotic liver disease (MASLD): Current knowledge of mechanismsHanyang Liu, Sander Lefere, Adrien Guillot, et al.Journal of Hepatology|July 14, 2019
Report on the AASLD/EASL joint workshop on clinical trial endpoints in NAFLDMary E Rinella, Frank Tacke, Arun J Sanyal, et al.Pageof 115